Mexican Pharma Prices Up 200%, And Still Rising

13 January 1997

Prices of Mexican medicines have increased by up to 200% in Mexico Cityand throughout the republic, and the price rises continue, according to the city's Health Commission, whose president, Arturo Saenz Ferrell, said this has placed medical products outside the reach of the majority of the population. This state of affairs is said to apply to both prescription and self-medication products.

Mr Saenz Ferrell alleges that laboratories making changes in packaging and contents have tripled prices over the past 12 months. And, according to the Association of Federal District Pharmacy Proprietors (Mexico City), the perennial problem of potential bankruptcies of smaller pharmacies continues due to this upward price movement.

Smaller pharmacies throughout the country are also being affected, as their sales are replaced by supermarkets and pharmacy chain stores which can buy at lower prices due to their large orders, transferring discounts to the public ranging from 20% to 30%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight